{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:25:45Z","timestamp":1781213145943,"version":"3.54.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Contrast-Associated Acute Kidney Injury (CA-AKI) is a major cause of acute kidney injury in hospitalized patients, which is triggered by the administration of iodinated contrast agents during computed tomography scans and angiographic procedures. It significantly elevates cardiovascular risk and stands as a major complication of coronary angiography, contributing to a marked deterioration in patient prognosis with elevated rates of morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Our main goal was to assess the predictive factors of CA-AKI and investigate a possible association between pre-existing endothelial dysfunction and the occurrence of CA-AKI following Percutaneous Coronary Interventions (PCI). We also intended to explore possible preventive measures of CA-AKI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective observational longitudinal study enrolling patients with an indication for PCI. Patients underwent an assessment of renal function (baseline creatinine, 24h and 48-72h after administration of contrast agent). We also evaluated renal function at one month as a secondary endpoint. Then, we analyzed Endothelial Quality Index (EQI) by Finger Thermal Monitoring (FTM) with E4 diagnosis Polymath.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We enrolled 187 patients (134 males, 53 females) in our study with a mean age of 61.1\u00b1 11.8 years. Over half (56.7%) were type 2 diabetes. A total of 60 cases of CA-AKI were reported (33.7%). The mean EQI was 0.86 \u00b1\u00a00.61. The vast majority of our study population (n=178; 95.2%) had endothelial dysfunction (EQI&amp;lt;2), and a significant proportion (n=142; 75.9%) had severe endothelial dysfunction (EQI&amp;lt;1). In our study, CA-AKI incidence was significantly associated with severe endothelial dysfunction (p=0.007). It was also strongly correlated to the rescue PCI (p=0.002), contrast media volume&amp;gt;100ml (p=0.015) and the presence of a two-vessel coronary artery disease (p=0.008). In multivariate analysis, severe endothelial dysfunction (OR\u00a0=\u00a05.46; p = 0.014), rescue PCI (OR\u00a0=\u00a05.77; p = 0.04) and contrast medica volume equal or over 140\u00a0ml (OR\u00a0=\u00a06.96; p = 0.036) were independent risk factors of CA-AKI. We found that pre- and post-hydration with isotonic saline solution and that patients whose baseline treatment includes statins, were significantly prevented from developing CA-AKI. (p=0.007 and 0.008 respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study showed a significant association between the presence of severe endothelial dysfunction, assessed non-invasively by FTM, and the risk of developing CA-AKI. These results appear to be relevant considering that EQI is a low-cost, non-invasive and easily reproducible marker of endothelial dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneph.2025.1582775","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:02:38Z","timestamp":1768892558000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["New insights into contrast-associated acute kidney injury: the key role of endothelial dysfunction"],"prefix":"10.3389","volume":"5","author":[{"given":"Mohamed","family":"Fakhfakh","sequence":"first","affiliation":[{"name":"Cardiology Department, Habib Bourguiba Hospital Medenine","place":["Medenine, Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Lassoued","sequence":"additional","affiliation":[{"name":"Cardiology Department, Habib Bourguiba Hospital Medenine","place":["Medenine, Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Nouri","sequence":"additional","affiliation":[{"name":"Cardiology Department, Habib Bourguiba Hospital Medenine","place":["Medenine, Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Ibn El Mechri","sequence":"additional","affiliation":[{"name":"Cardiology Department, Habib Bourguiba Hospital Medenine","place":["Medenine, Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Daly","sequence":"additional","affiliation":[{"name":"Cardiology Department, Habib Bourguiba Hospital Medenine","place":["Medenine, Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem","family":"Abdessalem","sequence":"additional","affiliation":[{"name":"Clinic Pasteur Tunis","place":["Tunis, Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad","family":"Ferjani","sequence":"additional","affiliation":[{"name":"Radiology Department, Habib Bourguiba Hospital Medenine","place":["Medenine, Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Milouchi","sequence":"additional","affiliation":[{"name":"Cardiology Department, Habib Bourguiba Hospital Medenine","place":["Medenine, Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-1402","article-title":"Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: A systematic review and meta-analysis","volume":"164","author":"Eng","year":"2016","journal-title":"Ann Intern Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.03.008","article-title":"Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification","volume":"93","author":"Bartholomew","year":"2004","journal-title":"Am J Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12228","DOI":"10.53738\/REVMED.2013.9.389.1222","article-title":"N\u00e9phropathie au produit de contraste","volume":"389","author":"Humbert","year":"2013","journal-title":"Rev Med Suisse"},{"key":"B4","first-page":"20610","article-title":"N\u00e9phropathie aux produits de contraste iod\u00e9s: mythe ou r\u00e9alit\u00e9","volume":"15","author":"Piller","year":"2019","journal-title":"Rev M\u00e9dicale Suisse"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1876","DOI":"10.6061\/clinics\/2021\/e1876","article-title":"Efficacy of short-term moderate or high-dose statin therapy for the prevention of contrast-induced nephropathy in high-risk patients with chronic kidney disease: systematic review and meta-analysis","volume":"76","author":"Zhou","year":"2021","journal-title":"Clin Sao Paulo Braz"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.4070\/kcj.2022.0093","article-title":"Strategies for renal protection in cardiovascular interventions","volume":"52","author":"Ali","year":"2022","journal-title":"Korean Circ J"},{"key":"B7","first-page":"41823","article-title":"Prevention of contrast-induced nephropathy","volume":"79","author":"Cousin","year":"2024","journal-title":"Rev Med Liege"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.06.068","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcard.2019.07.001","article-title":"Incidence and risk factors for contrast-induced nephropathy in patients undergoing cardiac catheterization","volume":"74","author":"Koo","year":"2019","journal-title":"J Cardiol"},{"key":"B10","article-title":"Contrast-induced nephropathy: Pathophysiology and prevention","volume":"25","author":"Pannu","year":"2012","journal-title":"J Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000190147","article-title":"Structural changes in the renal proximal tubular cells induced by iodinated contrast media","volume":"76","author":"Tervahartiala","year":"1997","journal-title":"Nephron"},{"key":"B12","first-page":"699","article-title":"The effects of iodinated contrast agents on renal vasculature and function","volume":"30","author":"Aksu","year":"2017","journal-title":"J Nephrol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs090","article-title":"Contrast-induced nephropathy and the risk of death after percutaneous coronary intervention: A prospective cohort study","volume":"33","author":"Charytan","year":"2012","journal-title":"Eur Heart J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.103226","article-title":"Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation","volume":"51","author":"Schiffrin","year":"2008","journal-title":"Hypertension"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury","volume":"51","author":"McCullough","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3390\/jpm13040701","article-title":"Contrast-induced acute kidney injury and endothelial dysfunction: the role of vascular and biochemical parameters","volume":"13","author":"Perrotta","year":"2023","journal-title":"J Pers Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"165961","DOI":"10.1093\/eurheartj\/ehae094","article-title":"Inorganic nitrate: a game changer in preventing contrast-associated acute kidney injury","volume":"45","author":"Zoccali","year":"2024","journal-title":"Eur Heart J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"164758","DOI":"10.1093\/eurheartj\/ehae100","article-title":"Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial","volume":"45","author":"Jones","year":"2024","journal-title":"Eur Heart J"},{"key":"B19","unstructured":""},{"key":"B20","doi-asserted-by":"publisher","first-page":"87165","DOI":"10.1093\/eurheartj\/ehz507","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.745758","article-title":"Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-endCOV study","volume":"8","author":"Charfeddine","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1348028","article-title":"New indices of endothelial function measured by digital thermal monitoring of vascular reactivity: data from 6084 patients registry","volume":"2016","author":"Naghavi","year":"2016","journal-title":"Int J Vasc Med"},{"key":"B23","unstructured":"Fiche de recommandation pour la pratique clinique_rein et produit de contraste.pdf"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1660359","article-title":"Influence of the type of volatile anesthetic on the development of acute kidney injury after endovascular repair of aortic aneurysm: a randomized controlled trial (DESEVAR study)","volume":"16","author":"Arnalich-Montiel","year":"2025","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1542776","article-title":"Preventive effect of sodium bicarbonate Ringer\u2019s solution on post-contrast acute kidney injury in patients undergoing percutaneous coronary intervention","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1618971","article-title":"High-mobility group box 1 in acute kidney injury","volume":"16","author":"Li","year":"2025","journal-title":"Front Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1538916","article-title":"Impact of Cordyceps sinensis on coronary computed tomography angiography image quality and renal function in a beagle model of renal impairment","volume":"16","author":"Song","year":"2025","journal-title":"Front Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2840-5-4","article-title":"Endothelial dysfunction: a comprehensive appraisal","volume":"5","author":"Esper","year":"2006","journal-title":"Cardiovasc Diabetol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"27K","DOI":"10.1016\/j.amjcard.2006.01.022","article-title":"Risk prediction of contrast-induced nephropathy","volume":"98","author":"McCullough","year":"2006","journal-title":"Am J Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"124550","DOI":"10.1111\/1440-1681.12479","article-title":"Microvascular resistance in response to iodinated contrast media in normal and functionally impaired kidneys","volume":"42","author":"Kurihara","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e32832c7d0b","article-title":"Contrast-induced nephropathy: role of nephrotoxic agents and their mechanisms of injury","volume":"18","author":"McCullough","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B32","doi-asserted-by":"publisher","first-page":"34650","DOI":"10.1161\/CIRCINTERVENTIONS.109.910638","article-title":"Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury","volume":"3","author":"Brown","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"B33","doi-asserted-by":"publisher","first-page":"64554","DOI":"10.1016\/j.jcin.2009.05.002","article-title":"The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials","volume":"2","author":"Reed","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7885","DOI":"10.1111\/j.1540-8183.2009.00523.x","article-title":"Contrast-induced nephropathy in patients undergoing elective and urgent procedures","volume":"23","author":"Mautone","year":"2010","journal-title":"J Interv Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.21037\/atm.2019.06.05","article-title":"The association between post-procedural oral hydration and risk of contrast-induced acute kidney injury among ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention","volume":"7","author":"Song","year":"2019","journal-title":"Ann Transl Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.ijcard.2016.07.086","article-title":"The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials","volume":"221","author":"Zhao","year":"2016","journal-title":"Int J Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e027","DOI":"10.1371\/journal.pone.0270000","article-title":"Impact of atorvastatin reload on the prevention of contrast-induced nephropathy in patients on chronic statin therapy: A prospective randomized trial","volume":"18","author":"Hammami","year":"2023","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.866113","article-title":"Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with long-COVID-19: insights from TUN-endCOV study","volume":"9","author":"Charfeddine","year":"2022","journal-title":"Front Cardiovasc Med"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1582775\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:02:40Z","timestamp":1768892560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1582775\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":38,"alternative-id":["10.3389\/fneph.2025.1582775"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2025.1582775","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"article-number":"1582775"}}